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Abstract. 
 
Connexins are gap junction proteins that 
form aqueous channels to interconnect adjacent cells. 
Rat osteoblasts express connexin43 (Cx43), which 
forms functional gap junctions at the cell surface. We 
have found that ROS 17/2.8 osteosarcoma cells, UMR 
106-01 osteosarcoma cells, and primary rat calvarial os-
teoblastic cells also express another gap junction pro-
tein, Cx46. Cx46 is a major component of plasma mem-
brane gap junctions in lens. In contrast, Cx46 expressed 
by osteoblastic cells was predominantly localized to an 
intracellular perinuclear compartment, which appeared 
to be an aspect of the TGN as determined by immuno-
fluorescence colocalization. Hela cells transfected with 
rat Cx46 cDNA (Hela/Cx46) assembled Cx46 into func-
tional gap junction channels at the cell surface. Both rat 
lens and Hela/Cx46 cells expressed 53-kD (nonphos-
phorylated) and 68-kD (phosphorylated) forms of 
Cx46; however, only the 53-kD form was produced by 
osteoblasts. To examine connexin assembly, monomers 
were resolved from oligomers by sucrose gradient ve-
locity sedimentation analysis of 1% Triton X-100Ðsolu-
bilized extracts. While Cx43 was assembled into multi-
meric complexes, ROS cells contained only the 
monomer form of Cx46. In contrast, Cx46 expressed by 
rat lens and Hela/Cx46 cells was assembled into multi-
mers. These studies suggest that assembly and cell sur-
face expression of two closely related connexins were 
differentially regulated in the same cell. Furthermore, 
oligomerization may be required for connexin trans-
port from the TGN to the cell surface.
 
G
 
ap
 
 junction channels mediate intercellular commu-
nication by allowing the direct transfer of ions and
small aqueous molecules between neighboring
cells. Gap junction channel proteins, or connexins, have
been identified with sizes in the range of 26Ð56 kD (for re-
views see 6, 7, 17, 21, 32). Channels composed of different
connexins have distinct properties, and most tissues ex-
press more than one connexin. There is increasing evi-
dence that multiple connexins can interact to form hetero-
meric gap junction channels (25, 52).
Regulation at the level of gene expression is clearly one
important way that gap junction composition can be regu-
lated (5, 10, 12, 14, 31, 50, 58). Connexin transport and
assembly into gap junction channels are other possible
points where cells can regulate the formation of gap junc-
tion channels (17, 38). A number of studies have shown
that newly synthesized connexins are transported through
the normal secretory apparatus (18, 39, 40, 46). However,
in contrast with most multimeric membrane protein com-
plexes that are formed in the ER (3, 13, 28), the identity of
the site of connexin oligomerization remains controversial
(32). Both ER (33) and Golgi apparatus (41) have been
suggested as sites for connexin assembly into gap junction
channels or hemichannels.
In previous studies we have examined the expression of
connexins in human and rat osteoblastic cells (11, 30, 53).
All of the cells examined express Cx43 (
 
a
 
1
 
) in junctional
plaques at the cell surface. In addition, some osteoblasts
also produce Cx45 (
 
a
 
6
 
), which also shows plasma mem-
brane localization (53). In this paper we have character-
ized a third endogenous connexin expressed by rat osteo-
blastic cells, Cx46 (
 
a
 
3
 
).
Cx46 expression has typically been associated with
plasma membrane gap junction channels in lens (14, 22,
25, 29, 43, 49, 57). We found that Cx46 was expressed by
primary rat osteoblastic cells and two osteosarcoma cell
lines, ROS-17/2.8 (ROS) and UMR 106-01 (UMR) cells.
In contrast with Cx43 and Cx45, Cx46 was largely retained
in an intracellular perinuclear compartment. Little, if any,
Cx46 accumulated on the cell surface, as determined by
immunofluorescence microscopy. Instead, Cx46 was re-
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tained in a 
 
trans
 
-aspect of the Golgi apparatus, probably
the TGN. In contrast, we found that Hela cells stably
transfected with rat Cx46 (Hela/Cx46) formed functional
gap junction channels by Cx46 at the plasma membrane.
In addition to the differential transport of Cx43 and
Cx46 by ROS cells, these cells also showed differences in
connexin assembly. While Cx43 was assembled into hex-
americ gap junction hemichannels by ROS cells, the intra-
cellular pool of Cx46 remained as unassembled mono-
mers. Thus, transport and assembly of Cx43 and Cx46 are
differentially regulated by osteoblastic cells. These data
are discussed in the context of potential roles for connexin
oligomerization in the regulation of transport.
 
Materials and Methods
 
Cells
 
ROS 17/2.8 and UMR 106-01 cells were cultured in MEM (No. 11095-056;
GIBCO BRL, Gaithersberg, MD) containing 10% heat-inactivated bo-
vine calf serum (BCS)
 
1
 
 (Hyclone, Logan, UT), 2 mM glutamine, 1 mM so-
dium pyruvate, 1% nonessential amino acids (GIBCO BRL), 5 U/ml pen-
icillin, and 5 
 
m
 
g/ml streptomycin (MEM 
 
1
 
 BCS). Primary osteoblastic cells
were isolated from fetal rat calvaria as previously described (51) and cul-
tured in MEM 
 
1
 
 BCS for no more than six passages. Hela cells were
kindly provided by Jeanette Pingle and Matthew Thomas (Washington
University, St. Louis, MO).
 
RNA Blots
 
Total cellular RNA was isolated using guanidium isothiocyanate and
probed for rat Cx46 and human 
 
g
 
-actin as previously described (30).
 
Antibodies
 
A number of immunological reagents were generous gifts from the follow-
ing researchers. Tissue-culture supernatant from murine hybridoma cells
producing anti-Cx50 (MP70; 
 
a
 
8
 
) was from Drs. J. Kistler (University of
Auckland, New Zealand) and D. Goodenough (Harvard University, Bos-
ton, MA) (14, 15). Tissue-culture supernatant containing monoclonal mu-
rine antiÐrat TGN38 was from Dr. G. Banting (University of Bristol, UK)
(24). Production of rabbit polyclonal antiserum that recognizes Cx43 was
previously described (4).
Rabbit antiÐCx46 IgG was produced using a 6His-tagged Cx46 fusion
protein. A cDNA consisting of the COOH-terminal tail sequence of rat
Cx46 was produced by PCR amplification using a full-length rat Cx46
cDNA as a template (sense primer: 5
 
9
 
-CGAGA GCGAC ATATG CTAGA
GATTT ACCAC CT-3
 
9
 
/antisense primer: 5
 
9
 
-AGCGA GCGGA TCCTT
TCTAC CTGTT GATTT GA-3
 
9
 
). The resulting PCR product was ampli-
fied and inserted into the pET-15b vector (Novagen, Madison, WI) to pro-
duce a bacterial expression vector containing cDNA encoding for a fusion
protein containing the Cx46 COOH terminus, a thrombin cleavage site,
and six histidine residues (Cx46-his). Bacterial expression of Cx46-his was
induced by treatment with isopropylthio-
 
b
 
-
 
d
 
-galactoside, cell extracts
were prepared, and Cx46-his was affinity purified using a nickel/His-Bind
chelation resin column (Novagen). This product was used to induce poly-
clonal antiserum in rabbits by established protocols.
Polyclonal serum that recognized Cx46 was initially identified by im-
munoblot analysis of rat lens total protein preparations that showed reac-
tive bands with the expected 
 
M
 
r
 
 at 53 and 68 kD, consistent with previous
reports (26, 29, 57). Preincubation of anti-Cx46 antiserum with antigen
eliminated binding to both bands in samples prepared from lens and ROS
cells (see Fig. 3, lanes 
 
2
 
 and 
 
4
 
). The perinuclear staining pattern obtained
for osteoblasts labeled with anti-Cx46 (e.g., see Fig. 2) was eliminated by
preincubation of the antiserum with Cx46-his protein (not shown). Also,
cells that do not express Cx46 did not show any labeling by immunofluo-
rescence or immunoblotting (see Fig. 4).
 
Immunofluorescence Microscopy
 
Cells were initially cultured on glass coverslips for 1Ð3 d before examina-
tion. The cells were washed twice in PBS, and then fixed and permeabil-
ized for 2 min at room temperature using methanol/acetone (1:1). The
cells were washed once with PBS containing 0.5% Triton X-100 and then
twice with PBS containing 0.5% Triton X-100 and 2% heat-inactivated
normal goat serum (PBS/TX/HIGS). The cells were then incubated with
primary antiserum diluted to optimal titer in PBS/TX/HIGS for 45Ð60 min
at room temperature. After washing three times with PBS/TX/HIGS, the
cells were further incubated with fluorescent anti-IgG diluted in PBS/TX/
HIGS for 45Ð60 min. The cells were then washed and viewed by fluores-
cence microscopy using appropriate optics. For Cx46 labeling, anti-Cx46
antiserum was diluted 1:1,000 into PBS/TX/HIGS, and the secondary anti-
serum was rhodamine-conjugated goat antiÐrabbit IgG (Boehringer Mann-
heim Biochemicals, Indianapolis, IN) diluted 1:500 in PBS/TX/HIGS. For
double labeling experiments, Cx43 was labeled using monoclonal antise-
rum from Zymed Laboratories (South San Francisco, CA), and staining
with fluorescent lectins was substituted for labeling with antisera to visual-
ize some organelles. In some instances, images were obtained with a Bio-
Rad MRC-1000 confocal fluorescence microscopy system (Hercules, CA);
all other images were obtained by epifluorescence microscopy using a
Zeiss Axioscope (Thornwood, NY) and GIPSSPC image processing sys-
tem (Georgia Instruments, Roswell, GA).
 
Protein Preparation and Immunoblotting
 
Total cell protein samples were prepared as previously described (30) and
resolved by SDS-PAGE using standard methods and 10% polyacrylamide
gels. The proteins were then electrophoretically transferred to polyvi-
nylidene difluoride (PVDF) membranes (transfer buffer: 50 mM Tris, 380
mM glycine, 0.025% (wt/vol) SDS, 20% MeOH), blocked with blotto (40
mM Tris, 5% (wt/vol) Carnation powdered milk, 0.1% (vol/vol) Tween-
20) for 1 h at room temperature, and then blocked overnight with antise-
rum diluted into blotto. The membranes were then washed, and specific
bands were detected using HRP-conjugated goat antiÐrabbit IgG (Tago,
Burlingame, CA) and enhanced chemiluminescence (ECL; Amersham Intl.,
Little Chalfont, UK). Cx50 immunoblots were detected using peroxidase-
conjugated goat antiÐmouse IgG 
 
1
 
 IgM (Boehringer Mannheim Biochemi-
cals). After a series of exposures, films showing unsaturated bands were digi-
tized and quantitated using an image analysis system (Georgia Instruments).
 
Sucrose Gradient Velocity Centrifugation
 
This procedure was adapted from that of Musil and Goodenough (40).
Cells cultured for 1Ð3 d in 100-mm tissue-culture dishes were washed
twice with PBS, and then scraped into PBS at 4
 
8
 
C and centrifuged at 500 
 
g
 
for 5 min. The cell pellet was resuspended in 2.75 ml incubation buffer
(0.14 M NaCl, 5.3 mM KCl, 0.35 mM Na
 
2
 
PO
 
4
 
, 0.35 mM KH
 
2
 
PO
 
4
 
, 0.8 mM
MgCl
 
2
 
, 2.7 mM Hepes, pH 7.4) containing protease (10 mM 
 
N
 
-ethylmale-
imide, 1 mM phenylmethylsulfonylchloride, 2 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml
pepstatin) and phosphatase inhibitors (1 mM NaVO
 
4
 
, 10 mM NaF) at 4
 
8
 
C
and homogenized with a ball-bearing cell homogenizer (1). The prepara-
tion was then centrifuged at 500 
 
g
 
 for 5 min to obtain a postnuclear super-
natant and brought to 1% Triton X-100. After a 30-min incubation at 4
 
8
 
C,
 
1. 
 
Abbreviations used in this paper
 
: BCS, bovine calf serum; BFA, brefel-
din A; NRK, normal rat kidney; PVDF, polyvinylidene difluoride.
Figure 1. Northern blot analysis
of Cx46 mRNA. Total RNA was
isolated from either ROS (lanes
1 and 3) and UMR (lanes 2 and
4) cells, subjected to agarose gel
electrophoresis, transferred to
membranes, and then hybridized
with a radiolabeled cDNA probe
for Cx46 (lanes 1 and 2). The
membranes were then stripped
and reprobed for actin as a con-
trol for mRNA loading (lanes 3
and  4). Dashes correspond to
28S and 18S rRNA. 
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the sample was centrifuged at 100,000 
 
g
 
 for 30 min to remove Triton-insol-
uble material, and then layered onto a 3.6-ml 5Ð20% sucrose gradient in
incubation buffer 
 
1
 
 0.1% Triton X-100 on top of a 0.2-ml 25% sucrose
cushion. Samples from intact lens were treated in a similar manner, except
that they were minced with a razor blade and incubated in 1% Triton X-100
for 12 h. The gradient was centrifuged using an SW55 rotor in a model L7-55
ultracentrifuge (Beckman Instruments, Inc., Palo Alto, CA) for 16 h at
148,000 
 
g.
 
 After centrifugation, samples were collected from the bottom of
the tube and diluted 1:1 with denaturing SDS sample buffer. Connexins
were detected by immunoblotting as described above.
 
Immunoprecipitation
 
ROS cells were incubated in methionine-deficient MEM containing 10%
dialyzed BCS for 1 h at 37
 
8
 
C, and then labeled for 5 h at 37
 
8
 
C with 300 
 
m
 
Ci
per dish 
 
35
 
S-Trans label (ICN Pharmaceuticals, Costa Mesa, CA). The
cells were then harvested, and Triton X-100Ðsoluble and Ðinsoluble frac-
tions were prepared as described above. The insoluble pool was resus-
pended, both fractions were diluted with PBS containing 0.25% BSA and
0.2% gelatin, and SDS was added to 0.5% final concentration. The sam-
ples were precleared with protein AÐSepharose and preimmune serum for
90 min at room temperature, and then incubated overnight with specific an-
tiserum and protein AÐSepharose that was preblocked with BSA and gela-
tin. The beads were washed, resuspended in reducing SDS-PAGE sample
buffer, and heated to 68
 
8
 
C to release proteins associated with the beads.
 
Transfection
 
Rat Cx46 cDNA was excised with EcoRI and inserted into the expression
vector pSFFVneo (8). Cx46/pSFFVneo was transfected into Hela cells by
calcium phosphate precipitation. The cells were incubated overnight at
37
 
8
 
C, and then shocked by treatment with 15% glycerol for 2 min. The
cells were then washed and plated in selective medium containing 1 mg/ml
G-418. Clones of G-418Ðresistant cells expressing Cx46 were identified by
immunofluorescence and immunoblotting.
 
Results
 
Cx46 Is Expressed by Osteoblasts
 
By Northern blot analysis, both ROS and UMR cells were
found to express Cx46 mRNA (Fig. 1). The intracellular
distribution of Cx43 and Cx46 was examined by indirect
Figure 2. Intracellular distribution of Cx46 in osteoblasts. (a and
b) Colocalization. ROS cells on glass coverslips were fixed, per-
meabilized, and double immunolabeled with monoclonal antiÐ
Cx43 mouse IgG and polyclonal antiÐCx46 rabbit IgG. The cells
were then labeled with rhodamine-conjugated goat antiÐmouse
IgG and FITC-conjugated goat antiÐrabbit IgG to visualize Cx43
(a) and Cx46 (b) by confocal microscopy. (Arrowheads) Cx43 lo-
calized to the cell surface; (arrows) Cx46 in the perinuclear re-
gion of the cell. (cÐf) Single label localization. UMR cells (c and
d) or rat calvarial cells (e and f) on glass coverslips were fixed,
permeabilized, and immunolabeled with either anti-Cx43 (c and
e) or anti-Cx46 (d and f) antiserum and rhodamine-conjugated
goat antiÐrabbit IgG. cÐf were obtained by epifluorescence mi-
croscopy. These cells also show the characteristic perinuclear ac-
cumulation of Cx46. Note that the immunofluorescence shown in
c represents an area showing very high levels of Cx43 expression
by UMR cells. Bar, 10 mm.
Figure 3. Immunoblot for Cx46 in lens and osteoblasts. (Lanes 1Ð4)
Samples from rat lens (lanes 1 and 2) and ROS (lanes 3 and 4)
were resolved by SDS-PAGE, electrophoretically transferred to
PVDF membranes, and then immunoblotted for Cx46. For lanes
2 and 4, the antiserum was preincubated with Cx46-his before im-
munoblotting, which blocked the recognition of Cx46. (Lanes 5Ð8)
Samples from rat lens (lane 5), ROS (lane 6), UMR (lane 7), and
primary rat calvarial cells (lane 8) were normalized for total pro-
tein and immunoblotted for Cx46. All three osteoblastic cell
types expressed the 53-kD form of Cx46. (Lanes 9 and 10) Sam-
ples from ROS cells corresponding to total cell protein were im-
munoblotted for either Cx43 (lane 9) or Cx46 (lane 10). Roughly
10-fold more protein was loaded for these lanes than the corre-
sponding sample in lane 6. Migration of molecular weight stan-
dards is indicated in the figure, and dots correspond to specific
protein bands. 
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immunofluorescence (Fig. 2). Consistent with our previous
work (30, 53), ROS and primary rat calvarial cells showed
high levels of Cx43 expression localized to areas where the
cells were in close contact, corresponding to gap junctions.
While UMR cells express relatively low levels of Cx43 as
compared with ROS cells (53), we were able to locate ar-
eas where Cx43 was immunolocalized to the cell surface
(Fig. 2 
 
c
 
). In contrast, all three cell types showed expres-
sion of Cx46. In each case, Cx46 was predominantly local-
ized to an intracellular compartment in the perinuclear re-
gion of the cell.
Lens cells typically show the highest levels of Cx46 ex-
pression (14, 22, 25, 29, 43, 49, 57). When total lens protein
extracts were examined by Western blotting, two forms of
Cx46 were found with 
 
M
 
r
 
 of 68 and 53 kD (Fig. 3, lanes 
 
1
 
and 
 
5
 
). This is consistent with previous reports, where the
68-kD band corresponds to a phosphorylated form of
Cx46 (26, 29) and may also have other posttranslational
modifications (29). In contrast, immunoblots of total pro-
teins isolated from ROS, UMR, and primary osteoblastic
cells derived from rat calvaria showed that these cells ex-
pressed only the 53-kD form of Cx46. This finding suggests
that Cx46 expressed by osteoblastic cells is likely to be
nonphosphorylated, although low levels of Cx46 phosphor-
ylation cannot be ruled out. Osteoblasts do not show a
general deficiency in connexin phosphorylation, since mul-
tiple forms of Cx43 corresponding to phosphorylated spe-
cies were observed in immunoblots of total protein sam-
ples from ROS cells (Fig. 3, lane 
 
9
 
) (38, 39). Also, ROS
cells showed qualitatively similar amounts of Cx43 and
Figure 4. Expression of Cx46 by transfected Hela cells. (a) Sam-
ples corresponding to Hela cells (lane 1) and Hela/Cx46 cells
(lane 2) were normalized for total protein, resolved by SDS/PAGE,
electrophoretically transferred to PVDF, and then immunoblot-
ted for Cx46. Faint nonspecific bands present in both lanes are
also observed in Western blots using preimmune serum (not
shown). (b and c) Untransfected Hela cells (b) or Hela/Cx46 cells
(c) plated on glass coverslips were fixed, permeabilized, and then
immunolabeled with anti-Cx46 and rhodamine-conjugated goat
antiÐrabbit IgG. Both images were obtained using the same expo-
sure conditions. Hela/Cx46 cells showed Cx46 present both on
the cell surface (arrows) and in the perinuclear region of the cell.
Figure 5. Dye transfer by Hela/Cx46 cells. Untransfected Hela
cells and Hela/Cx46 cells were cultured on glass coverslips. (a and
b) Phase-contrast (a) and fluorescence (b) images of one non-
transfected Hela cell in a monolayer that was microinjected with
10 mg/ml Lucifer yellow (*). Hela cells showed no intercellular
transfer of Lucifer yellow. (cÐf) Hela/Cx46 cells were microin-
jected with a mixture of 10 mg/ml Lucifer yellow and 5 mg/ml
Texas red ovalbumin. While Texas red was retained in the micro-
injected cell (c and e), Hela/Cx46 cells showed intercellular trans-
fer of Lucifer yellow to some nearest neighbors (d and f).Koval et al. Monomeric Cx46 Retained in the TGN 851
Cx46 expression, as determined by immunoblotting (Fig.
3, lanes 9 and 10).
Elfgang et al. (16) found that Hela cells were highly defi-
cient in connexin expression. We confirmed by Western
blotting and immunofluorescence that wild-type Hela cells
did not express Cx46 (Fig. 4), Cx43, or Cx50 (not shown).
Thus, Hela cells were stably transfected with rat Cx46
cDNA (Hela/Cx46) to examine the targeting of Cx46 in
nonosteoblastic cells.
In contrast with osteoblasts, Cx46 was present at the cell
surface of Hela/Cx46 cells, as well as in intracellular com-
partments (Fig. 4 c). While these cells were not extensively
coupled, Cx46 expressed by Hela/Cx46 cells formed func-
tional gap junction channels, as determined by intercellu-
lar transfer of microinjected Lucifer yellow (Fig. 5). Texas
red ovalbumin did not transfer between Hela/Cx46 cells.
This indicates that retention of Cx46 in an intracellular
compartment depends upon the cell type examined. Fur-
thermore, since Cx46 was readily detected at the surface of
Hela/Cx46 cells, it is likely that accumulation of apprecia-
ble amounts of Cx46 on the osteoblast cell surface would
be visible by immunofluorescence microscopy. However,
this does not rule out the possibility that Cx46 is trans-
ported to the cell surface and rapidly cleared by reinter-
nalization.
The expression of Cx46 by transfected Hela cells was
also examined by immunoblotting (Fig. 4 a). Hela/Cx46
cells showed both the 68- and 53-kD forms of Cx46 that
are found associated with lens. This contrasts with results
obtained with osteoblastic cells, where only the lower mo-
lecular mass form was present (Fig. 3). Thus, the ability to
produce the 68-kD form of Cx46 correlated with the abil-
ity to form gap junctions containing Cx46. Whether one
process is a prerequisite for the other is not known at
present.
Cx46 Is Retained in the TGN
The identity of the intracellular compartment containing
Cx46 was determined with a series of fluorescence colo-
calization experiments in ROS cells. To label endocytic
compartments, cells were incubated at 378C for 1 h with
medium containing the fluorescent fluid phase marker, Lu-
cifer yellow. ROS cells labeled in this manner were fixed
and immunostained for Cx46, and then examined by fluo-
rescence microscopy. In these double-labeled cells, fluo-
rescently labeled endocytic compartments and intracellu-
lar vesicles containing Cx46 showed distinct intracellular
distributions (Fig. 6, a and b).
ER in fixed and permeabilized cells was preferentially
labeled using a fluorescent lectin, fluorescein-conjugated
conconavalin A (FITC-ConA), which recognizes the high
mannose core oligosaccharide component of glycopro-
teins. Areas of the ER that are prominently labeled with
FITC-ConA, such as the nuclear envelope and lattices in
the periphery of the cell, showed little labeling for Cx46
(Fig. 6, c and d).
The Cx46-containing compartment in ROS cells colocal-
ized with the Golgi apparatus by double-labeling immu-
nofluorescence using a marker for the medial-Golgi stack
(anti-GCI) (9). As shown in Fig. 7, a and b, both the anti-
GCI and Cx46 showed prominent perinuclear localization.
However, these two proteins were in distinct compart-
ments. This was revealed by treatment of the cells with
brefeldin A (BFA), which preferentially disassembles cis
and medial aspects of the Golgi apparatus (54). When
ROS cells were preincubated for 5 min with BFA and then
fixed and examined by immunofluorescence, the GCI
marker redistributed to the periphery of the cell, while the
Cx46 staining pattern was relatively intact (Fig. 7, c and d).
This suggests that Cx46 was located in a secretory com-
partment beyond the medial Golgi, either the trans-Golgi
cistern or the TGN.
To further examine this possibility, we performed colo-
calization experiments using a monoclonal antiÐrat TGN38
antibody (24). As shown in Fig. 7, e and f, both Cx46 and
TGN38 colocalize to the perinuclear region of the cell. The
distribution of these two proteins was not affected by short-
term treatment with BFA (not shown). However, in cells
incubated for 30 min in the presence of BFA, both Cx46
and TGN38 condensed into the same concentrated spot in
Figure 6. Cx46 is not localized to either endocytic or ER com-
partments. (a and b) ROS cells on glass coverslips were incubated
for 1 h at 378C in medium containing 10 mg/ml Lucifer yellow to
label endocytic compartments (a). The cells were then fixed with
paraformaldehyde, permeabilized using 0.2% Triton X-100,
immunostained for Cx46 (b), and visualized by epifluorescence
microscopy. The intracellular distribution of Lucifer yellow was
distinct from the pattern observed for Cx46. (c and d) ROS cells
on glass coverslips were fixed and permeabilized using methanol/
acetone (50/50) and labeled with FITC-ConA (c). The cells were
then immunostained using anti-Cx46 antiserum and rhodamine-
conjugated goat antiÐrabbit IgG (d). c and d were obtained by
confocal microscopy. Colocalization between Cx46 and FITC-
ConA, which preferentially labeled elements of the ER, was lim-
ited. In particular, note that low levels of Cx46 labeling were
present in the nuclear envelope (arrowhead).The Journal of Cell Biology, Volume 137, 1997 852
the nuclear region (Fig. 7, g and h). This is similar to the
pattern of TGN38 labeling in normal rat kidney (NRK)
cells treated for 30Ð60 min with BFA (34, 48). Taken to-
gether, these observations suggest that the intracellular
pool of Cx46 likely corresponds to an aspect of the TGN.
We attempted to stimulate the transport of Cx46 to the
plasma membrane by plating osteoblastic cells under a va-
riety of culture conditions. Under the conditions exam-
ined, little, if any, Cx46 was found to be localized to the
cell surface. We also incubated ROS cells for short periods
(2Ð12 h) before immunofluorescence labeling with a num-
ber of agents known to affect bone cell metabolism (47),
such as b-glycerophosphate (2.3Ð5.8 mM) 1 ascorbate
(0.1Ð0.25 mg/ml), dexamethasone (10Ð250 mM), PMA (0.1
mM) 6 bromo-A23187 (0.1 mg/ml), parathyroid hormone
(0.125Ð1.0  mM),  b-estradiol (0.5Ð50 mg/ml), 1,25-dihy-
droxy-vitamin D3 (5Ð25 ng/ml), and dibutyryl-cAMP (0.1
mM), as well as a variety of plating densities and mechani-
cal stress. None of these treatments altered the intracellu-
lar distribution of Cx46 in ROS cells.
Osteoblasts Retain Cx46 as a Monomer
To examine the assembly of Cx43 and Cx46, we used tech-
niques previously described by Musil and Goodenough
(40) using 1% Triton X-100 at 48C, conditions that enable
the solubilization of intact Cx43 hexamers in other cell
types. Cx43 and Cx46 were solubilized to different extents
(Fig. 8). Note that Cx43 already assembled into gap junc-
tional plaques is resistant to solubilization under these
conditions (39). As determined by immunoprecipitation
analysis, z50% of the Cx43 in ROS cells was soluble in
1% Triton X-100 at 48C, while virtually all of the Cx46 was
solubilized under the same conditions.
Detergent-extracted connexin preparations were re-
solved into monomers and multimers by sucrose gradient
velocity sedimentation (Fig. 9). Cx43 from ROS cells re-
solved into two fractions. The major fraction centered at
8% sucrose corresponds to Cx43 monomers, while the
peak at 15% sucrose corresponds to multimers. Multimeric
Figure 7. Cx46 is in a trans-
Golgi compartment. (a and
b) ROS cells on glass cover-
slips were fixed, permeabi-
lized, and immunolabeled
with mAbs that recognize a
medial-Golgi protein (GCI).
The cells were also immuno-
stained for Cx46 using poly-
clonal antiserum, and then
labeled with rhodamine-con-
jugated goat antiÐmouse IgG
(a) and FITC-conjugated goat
antiÐrabbit IgG (b). (c and d)
ROS cells on glass coverslips
were preincubated in MEM
containing 10 mg/ml brefel-
din A (BFA) for 5 min at
378C. The cells were then
fixed, permeabilized, and im-
munolabeled for GCI (c) and
Cx46 (d). aÐd were obtained
by confocal microscopy. While BFA disrupts the medial Golgi, Cx46 remains in the perinuclear region (arrow). (e and f) ROS cells on
glass coverslips were fixed, permeabilized, and immunolabeled with mAbs that recognize TGN38 (e) and Cx46 using polyclonal antise-
rum (f). (g and h) ROS cells on glass coverslips were preincubated in MEM containing 10 mg/ml BFA for 30 min at 378C. The cells were
then fixed, permeabilized, and immunolabeled for TGN38 (g) and Cx46 (h). eÐh were obtained by epifluorescence microscopy. Under
these conditions, both proteins condense into a dot in the center of the cell (arrowheads).
Figure 8. Triton solubility of Cx43 and Cx46 in ROS cells. ROS
cells were metabolically radiolabeled with 35S-Trans label, har-
vested, homogenized, and solubilized in 1% Triton X-100 at ei-
ther room temperature (lane 1) or 48C (lanes 2Ð5) for 30 min. Tri-
ton-soluble (lanes 1, 2, and 4) and -insoluble (lanes 3 and 5)
fractions were analyzed by immunoprecipitation using antisera
that recognizes either Cx43 (lanes 1Ð3) or Cx46 (lanes 4 and 5).
Note that the Cx46 band (lane 4) was somewhat distorted due to
the presence of high levels of IgG heavy chain required for im-
munoprecipitation. At 48C, Cx46 showed complete Triton X-100
solubility, while Cx43 was only partially soluble (lane 2). Migra-
tion of molecular weight standards is indicated in the figure, and
dots correspond to specific protein bands.Koval et al. Monomeric Cx46 Retained in the TGN 853
Cx43 consisted of 21.4 6 2.8% (n 5 3) of the total Triton
X-100Ðsoluble Cx43. The preponderance of Cx43 mono-
mers over hexamers was expected, since the Triton-solu-
ble fraction of Cx43 is likely to contain mostly newly syn-
thesized Cx43 (39, 40). However, some monomeric Cx43
may be due to spontaneous disassembly of hexameric Cx43
during the course of the experiment.
Treatment of NRK cells with BFA inhibits the oligo-
merization of Cx43, suggesting that Cx43 is assembled into
oligomers in a late Golgi apparatus compartment (40). If
this is the case, then treatment of ROS cells with mon-
ensin, which inhibits cis to medial transport through the
Golgi apparatus, should also inhibit Cx43 oligomerization.
As shown by immunofluorescence microscopy in Fig. 10,
monensin-treated ROS cells showed Cx43 and Cx46 re-
tained in a similar perinuclear region of the cell. This is
consistent with results obtained with monensin-treated
cardiac myocytes (45). When oligomerization of Cx43 was
examined in monensin-treated cells, only 8% (n 5 2) of
the Triton-soluble Cx43 isolated from monensin-treated
cells was assembled into multimers, as compared with con-
trol cells that had two- to threefold more Cx43 in the
hemichannel form (Fig. 11). Also, since we could detect
this difference in the amount of Cx43 assembled into
hemichannels, it is likely that nonspecific aggregation of
Cx43 did not occur during the solubilization and sucrose
gradient fractionation procedure.
In contrast with Cx43, Cx46 solubilized from ROS cells
migrated as a single peak centered at 8% sucrose (Fig. 9 b).
Since nearly all of the Cx46 was soluble in 1% Triton X-100,
this suggests that all of the Cx46 was being retained by
ROS cells in a monomeric form.
One possible concern in using Triton X-100Ðsolubilized
preparations is that Cx46-containing oligomers may not be
stable under these conditions. To examine this possibility,
we prepared Triton X-100Ðsoluble extracts from both
Hela/Cx46 cells and whole rat lens. While Hela/Cx46 cells
were solubilized using the same conditions used for ROS
Figure 9. Sucrose gradient analysis of Cx43 and Cx46 oligomer-
ization. ROS cells were harvested and homogenized, and Triton
X-100 was added to a final concentration of 1%. After an incuba-
tion for 30 min at 48C, the preparation was centrifuged at 50,000 g
for 30 min, and the resulting Triton-soluble fraction was layered
onto a 5Ð20% sucrose gradient containing 0.1% Triton X-100
(with a 25% sucrose cushion). The gradient was centrifuged for
16 h at 148,000 g. Fractions were collected from the bottom of the
tube, diluted 1:1 with sample buffer, resolved by SDS-PAGE,
and  electrophoretically transferred to PVDF membranes. Cx43 (a
and c) and Cx46 (b and d) were detected by immunoblotting (c
and d) and quantified by densitometry (a and b). Lanes in c and d
are labeled with the corresponding sample sucrose concentration,
which was determined by refractometry.
Figure 10. Cx43 and Cx46 are retained in the same compartment
in the presence of monensin. ROS cells on glass coverslips were
preincubated in MEM containing 10 mM monensin for 4 h at 378C.
The cells were then fixed, permeabilized, and immunolabeled for
Cx43 (a) and Cx46 (b) as described in Fig. 1.The Journal of Cell Biology, Volume 137, 1997 854
cells, extensive incubation with 1% Triton X-100 at 48C
was required to solubilize detectable amounts of material
from rat lens. Both the 53- and 68-kD forms of Cx46 were
solubilized under these conditions (Figs. 12 and 13).
When Triton X-100Ðsoluble extracts from lens were ex-
amined by sucrose gradient fractionation, the majority of
the Cx46 was found to be in oligomeric forms (Fig. 12 a).
We also examined this gradient for Cx50, another abun-
dant lens connexin (14, 15). The profile for Cx50 was very
comparable to that observed for Cx46 in lens (Fig. 12 b).
Similar results were obtained by sucrose gradient analysis
of Cx46 solubilized from Hela/Cx46 cells, although the
Figure 11. Monensin inhibits Cx43 oligomerization in ROS cells.
Cells were incubated in either the absence (a) or presence (b) of
10 mM monensin for 4 h at 378C. The cells were then harvested
and homogenized, and Triton X-100 was added to a final concen-
tration of 1%. After an incubation for 30 min at 48C, the prepara-
tion was centrifuged at 50,000 g for 30 min, and the resulting su-
pernatant was analyzed by sucrose gradient fractionation as
described above. Cx43 in control (a and c) and monensin-treated
(b and d) cells were detected by immunoblotting (c and d) and
quantified by densitometry (a and b). Monensin treatment, which
inhibits transport from the cis- to medial-Golgi compartments,
also inhibited Cx43 oligomerization.
Figure 12. Connexin hemichannels from rat lens are stable in Tri-
ton X-100. Connexins solubilized from rat lenses were analyzed
by sucrose gradient fractionation as described above. Cx46 (a and
c) and Cx50 (b and d) were detected by immunoblotting and
quantified by densitometry (a and b). Symbols in a correspond to
measurements of total Cx46 (d) and the 53-kD form of Cx46 (j). Koval et al. Monomeric Cx46 Retained in the TGN 855
peak at 14Ð18% was significantly reduced (Fig. 13 a). The
sucrose gradient profiles of Cx46 isolated from lens and
Hela/Cx46 cells are consistent with the notion that multi-
mers containing Cx46 were largely stable in the presence
of Triton X-100. This is further supported by Fig. 13 b,
where Cx46 extracted from Hela/Cx46 cells and then dis-
sociated by treatment with 0.2% SDS migrated on the gra-
dient as a single peak at 8Ð9% sucrose.
Discussion
In this paper we have examined the expression of Cx46 by
osteoblastic, lens, and transfected Hela cells. Osteoblastic
cells retained Cx46 as a monomer in an intracellular com-
partment that is likely to be an aspect of the TGN. In con-
trast, Cx46 was assembled into oligomers by lens and
Hela/Cx46 cells and transported to the cell surface. This
raises the possibility that connexin assembly and transport
are interlinked and regulated processes.
Connexins are assembled into a hemichannel in an in-
tracellular compartment before transport to the plasma
membrane (33, 40). This hemichannel then pairs with an-
other hemichannel on a neighboring cell to form a com-
plete gap junction channel. There is evidence supporting
both ER and Golgi apparatus as sites for connexin oligo-
merization. Kumar et al. (33) have found by EM that BHK
cells transfected with Cx32 (b1) form intracellular gap
junctional structures in the ER as well as the plasma mem-
brane. This indicates that Cx32 assembly into hemichan-
nels also occurred at the ER and is consistent with Òclassi-
calÓ models for transmembrane protein assembly (3, 13,
28). An alternative model has been proposed by Musil and
Goodenough (40). Using sucrose gradient fractionation to
analyze connexin assembly, they found that Cx43 is assem-
bled in a late Golgi compartment of NRK and CHO cells,
most likely the TGN. When cells were treated with BFA,
oligomerization was inhibited. Similar results were ob-
tained using temperature-sensitive mutant cell lines defi-
cient in ER to Golgi transport.
We used sucrose gradient fractionation to examine the
oligomerization state of Cx43 and Cx46 present in Triton
X-100 extracts. Treatment of ROS cells with monensin,
which inhibited cis- to medial-Golgi transport, also re-
duced Cx43 hemichannel formation by .62% (Fig. 10).
While this evidence is not conclusive, it is consistent with a
trans-Golgi compartment as the site of Cx43 oligomeriza-
tion in this system. Since Cx43 assembly was not com-
pletely inhibited, it is possible that Cx43 hemichannels
may also be assembled in the ER. Alternatively, some of
the hemichannels that we detected in the presence of mon-
ensin may be due to Cx43 disassembled from gap junctions
that is en route to degradation.
We found that Cx46 oligomers were stable in Triton X-100
(Figs. 12 and 13). Sucrose gradients have also been used to
analyze connexin channels isolated from ovine lens (25).
Analogous to chick, ovine, and bovine lens (25, 29), it is
likely that most hemichannels isolated from rat lens con-
tained Cx50 in addition to Cx46. Preliminary analysis of
ROS and UMR cells indicates that these cells do not ex-
press Cx50 (not shown). An absolute requirement for
Cx50 is not likely for Cx46 incorporation into gap junction
channels, since we found that Hela/Cx46 cells were able to
form functional gap junctions in the absence of Cx50, al-
beit at relatively low levels. Formation of gap junctions
purely from Cx46 has also been described in other systems
(59, 60).
Figure 13. Connexin hemichannels from Hela/Cx46 cells are sta-
ble in Triton X-100. Connexins solubilized from Hela/Cx46 cells
were further incubated at 48C for 1 h in either the absence (a and
c) or presence (b and d) of 0.2% SDS, and then analyzed by su-
crose gradient fractionation as described above. Symbols corre-
spond to measurements of total Cx46 (d) and the 53-kD form of
Cx46 (j). In the presence of SDS, Cx46 oligomers dissociated
into monomers that migrated on the sucrose gradient as a single
peak centered at 8Ð9% sucrose.The Journal of Cell Biology, Volume 137, 1997 856
Cx46 was retained in a monomer, rather than a hemi-
channel form, by ROS cells. Based on colocalization ex-
periments shown above, it seems likely that osteoblasts
transported Cx46 to compartments where connexin oligo-
merization occurs. This is consistent with a requirement
for connexin oligomerization as a prerequisite for trans-
port from the TGN and/or retention at the cell surface.
The notion of quality control at the level of the Golgi ap-
paratus is supported by the observation that some mutant
viral glycoproteins exit the ER without being properly as-
sembled, but are retained in the Golgi apparatus (20, 42).
Immunofluorescence was used to determine whether
Cx46 was present at the plasma membrane of osteoblastic
cells. This technique does not completely rule out the pos-
sibility that Cx46 transport to the cell surface occurs, but
suggests that it is rapidly reinternalized after delivery to
the plasma membrane. TGN38 (48) and furin (37, 56) are
examples of proteins that continuously recycle at low lev-
els between the TGN and plasma membrane, yet are not
readily detectable at the cell surface by conventional indi-
rect immunofluorescence. Furthermore, the communica-
tion-deficient cell lines L929 and S180, which do not show
accumulation of Cx43 at the plasma membrane by immu-
nofluorescence (41), contain a pool of Cx43 that is accessi-
ble by surface biotinylation (39). Interestingly, S180 and
L929 cells show low levels of Cx43 phosphorylation (41),
analogous to our observations with Cx46 in osteoblasts.
However, these situations are not completely comparable,
since both S180 and L929 cells assemble Cx43 into hemi-
channels (40). Cx43 hemichannels at the cell surface have
also been observed in other systems (35).
It is also possible that Cx46 is transported by osteoblasts
along a regulated secretory pathway that is distinct from
the transport pathway for Cx43. Rat uterine myometrial cells
provide a precedent for the stimulated transport of con-
nexins to form gap junctions (2, 10, 19, 23, 44). Whether
the intracellular compartment containing Cx46 is a regu-
lated secretory compartment is not known at present.
However, storage vesicles that accumulate other trans-
membrane proteins subject to stimulated transport to the
plasma membrane, such as GLUT4, accumulate in the
perinuclear region in other cell types (27, 36).
Since Cx43 and Cx46 had distinct intracellular distribu-
tions in osteoblastic cells, this indicates that these two con-
nexins were not randomly intermixing in these cells. It is
not known whether Cx43 and Cx46 can form heteromeric
channels in other systems, and there is no a priori reason
that these two a-connexins cannot intermix. In fact, Cx43
has been observed to colocalize near lens gap junctional
plaques that also contain Cx46 (14). Also, Cx43 and Cx46
expressed by Xenopus oocytes can form functional hetero-
typic channels (55, 59).
Since Cx43 and Cx46 have different fates in osteoblastic
cells, our data support the notion that connexin transport
is a specific process and not due to the bulk flow of con-
nexins along a ÒdefaultÓ secretory pathway. Also, oligo-
merization seems to be interconnected with connexin tar-
geting and transport to the cell surface. Further work will
be required to find structural determinants that either tar-
get connexins to specific intracellular locations or control
connexin transport at the level of gap junction channel as-
sembly.
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